February 16,2006
Senator Grassley's Statement for the Record regarding FDA's Approval Process
Please see the following two documents attached as related files:
(1) Grassley Statement from the Feb. 16 Congressional Record
(2) Report of the Committee Staff Review of the FDA’s Approval Process for the Vagus Nerve Stimulation Therapy System for Treatment-Resistant Depression
Next Article Previous Article
Recent News
- Working Families Tax Cuts Drive Investment to Local Communities
- Crapo, Wyden, Colleagues Call on Trump to Prioritize Opening Japanese Market Access to U.S. Potato Industry
- Working Families Tax Cuts Celebrate Employees
- Support Grows for Taxpayer Assistance and Service Act
- Working Families Tax Cuts Support the Next Generation